Abstract

Congenital adrenal hyperplasia (CAH) is the most common primary adrenal insufficiency in children, involving excess androgens secondary to disrupted steroidogenesis as early as the seventh gestational week of life. Although structural brain abnormalities are seen in CAH, little is known about facial morphology. To investigate differences in facial morphologic features between patients with CAH and control individuals with use of machine learning. This cross-sectional study was performed at a pediatric tertiary center in Southern California, from November 2017 to December 2019. Patients younger than 30 years with a biochemical diagnosis of classical CAH due to 21-hydroxylase deficiency and otherwise healthy controls were recruited from the clinic, and face images were acquired. Additional controls were selected from public face image data sets. The main outcome was prediction of CAH, as performed by machine learning (linear discriminant analysis, random forests, deep neural networks). Handcrafted features and learned representations were studied for CAH score prediction, and deformation analysis of facial landmarks and regionwise analyses were performed. A 6-fold cross-validation strategy was used to avoid overfitting and bias. The study included 102 patients with CAH (62 [60.8%] female; mean [SD] age, 11.6 [7.1] years) and 59 controls (30 [50.8%] female; mean [SD] age, 9.0 [5.2] years) from the clinic and 85 controls (48 [60%] female; age, <29 years) from face databases. With use of deep neural networks, a mean (SD) AUC of 92% (3%) was found for accurately predicting CAH over 6 folds. With use of classical machine learning and handcrafted facial features, mean (SD) AUCs of 86% (5%) in linear discriminant analysis and 83% (3%) in random forests were obtained for predicting CAH over 6 folds. There was a deviation of facial features between groups using deformation fields generated from facial landmark templates. Regionwise analysis and class activation maps (deep learning of regions) revealed that the nose and upper face were most contributory (mean [SD] AUC: 69% [17%] and 71% [13%], respectively). The findings suggest that facial morphologic features in patients with CAH is distinct and that deep learning can discover subtle facial features to predict CAH. Longitudinal study of facial morphology as a phenotypic biomarker may help expand understanding of adverse lifespan outcomes for patients with CAH.

Highlights

  • Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is an inherited disorder affecting 1 in 15 000 in the severe, classical form and 1 in 1000 in the mild, nonclassical form.[1]

  • With use of classical machine learning and handcrafted facial features, mean (SD) area under curve (AUC) of 86% (5%) in linear discriminant analysis and 83% (3%) in random forests were obtained for predicting CAH over 6 folds

  • The findings suggest that facial morphologic features in patients with CAH is distinct and that deep learning can discover subtle facial features to predict CAH

Read more

Summary

Introduction

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is an inherited disorder affecting 1 in 15 000 in the severe, classical form and 1 in 1000 in the mild, nonclassical form.[1]. The effects of excess androgens in utero can be readily seen in female newborns with CAH as virilized external genitalia.[3] Females with CAH exhibit masculinization of childhood behaviors, including male-typical play preferences, aggression, and altered cognition (eg, spatial ability).[4,5,6,7,8] Concerning adverse neuropsychological outcomes have been identified over the lifespan of patients with CAH, including a heightened potential for psychiatric disorders, substance abuse, and suicide,[9,10] and brain structural abnormalities have been identified in youths and adults with CAH (eg, smaller intracranial volume and smaller regions of the prefrontal cortex and medial temporal lobe).[11,12,13,14] The association between these outcomes and prenatal hormone abnormalities remains unclear, with a lack of a robust modeling system and a set of biomarkers. Amniocentesis to examine prenatal hormones is invasive and not readily available

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call